PriceTargets.com logo

Ares Commercial Real Estate - ACRE Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $5.08
  • Forecasted Upside: -1.20%
  • Number of Analysts: 6
  • Breakdown:
  • 1 Sell Ratings
  • 5 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$5.15 As of 12/4/2025 04:59 PM ET
▼ -0.155 (-2.92%)

This chart shows the closing price for ACRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ares Commercial Real Estate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACRE

Analyst Price Target is $5.08
▼ -1.20% Downside Potential
This price target is based on 6 analysts offering 12 month price targets for Ares Commercial Real Estate in the last 3 months. The average price target is $5.08, with a high forecast of $5.50 and a low forecast of $4.75. The average price target represents a -1.20% upside from the last price of $5.15.

This chart shows the closing price for ACRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 6 polled investment analysts is to reduce stock in Ares Commercial Real Estate. This rating has held steady since February 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2025UBS GroupBoost TargetNeutral ➝ Neutral$4.50 ➝ $5.00
11/11/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$4.50 ➝ $4.75
10/9/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$4.25 ➝ $4.50
10/8/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
9/27/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
8/11/2025Zacks ResearchUpgradeHold
8/6/2025UBS GroupLower TargetNeutral ➝ Neutral$5.00 ➝ $4.50
8/6/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$4.80 ➝ $4.25
7/10/2025Keefe, Bruyette & WoodsBoost TargetMarket Perform ➝ Market Perform$4.50 ➝ $4.80
5/21/2025UBS GroupBoost TargetNeutral ➝ Neutral$3.75 ➝ $5.00
4/21/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
4/16/2025UBS GroupLower TargetNeutral ➝ Neutral$5.25 ➝ $3.75
4/7/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$5.50 ➝ $4.50
2/25/2025UBS GroupLower TargetNeutral ➝ Neutral$6.00 ➝ $5.25
2/13/2025JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$6.00 ➝ $5.50
2/13/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$6.00 ➝ $5.50
2/13/2025JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
1/21/2025JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$7.00 ➝ $6.00
1/14/2025Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$7.00 ➝ $6.00
12/9/2024JMP SecuritiesReiterated RatingMarket Perform ➝ Market Perform
10/17/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$7.00 ➝ $6.50
9/20/2024Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$7.50 ➝ $7.00
7/19/2024BTIG ResearchReiterated RatingNeutral
5/10/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$7.50 ➝ $7.00
4/10/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$8.00 ➝ $7.50
4/10/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$8.00 ➝ $7.00
3/20/2024UBS GroupLower TargetNeutral ➝ Neutral$10.50 ➝ $8.00
3/4/2024Bank of AmericaReiterated RatingBuy ➝ Underperform$11.00 ➝ $7.00
2/26/2024Keefe, Bruyette & WoodsLower TargetMarket Perform ➝ Market Perform$10.25 ➝ $8.00
2/23/2024JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$9.50 ➝ $8.00
12/6/2023UBS GroupInitiated CoverageNeutral$10.50
12/5/2023JMP SecuritiesDowngradeOutperform ➝ Market Perform
9/13/2023Wells Fargo & CompanyInitiated CoverageEqual Weight$10.00
8/18/2023Raymond James FinancialDowngradeOutperform ➝ Market Perform
8/3/2023JMP SecuritiesBoost TargetOutperform ➝ Outperform$11.00 ➝ $11.50
7/24/2023JPMorgan Chase & Co.Boost Target$8.00 ➝ $10.00
5/3/2023Raymond James FinancialLower Target$13.50 ➝ $10.50
5/3/2023JMP SecuritiesLower Target$13.50 ➝ $11.00
4/25/2023BTIG ResearchDowngradeBuy ➝ Neutral
4/24/2023JPMorgan Chase & Co.Lower Target$11.00 ➝ $9.00
4/13/2023Keefe, Bruyette & WoodsLower TargetMarket Perform$12.50 ➝ $10.00
3/7/2023Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$12.50
11/2/2022BTIG ResearchLower Target$16.50 ➝ $14.00
10/31/2022Bank of AmericaReiterated RatingBuy ➝ Buy$13.00
10/24/2022JPMorgan Chase & Co.Lower TargetNeutral$13.50 ➝ $12.00
10/18/2022Raymond James FinancialLower TargetOutperform$15.00 ➝ $13.50
10/14/2022JMP SecuritiesLower TargetMarket Outperform$15.00 ➝ $13.50
10/13/2022Credit Suisse GroupLower Target$13.50
8/1/2022JMP SecuritiesLower TargetMarket Outperform$16.50 ➝ $15.00
7/22/2022Credit Suisse GroupLower Target$14.50
5/24/2022JMP SecuritiesReiterated RatingBuy$16.50
4/25/2022JPMorgan Chase & Co.Boost TargetNeutral$14.50 ➝ $16.00
3/31/2022JMP SecuritiesBoost TargetMarket Outperform$16.00 ➝ $16.50
11/12/2021BTIG ResearchReiterated RatingBuy$16.50
11/4/2021JMP SecuritiesBoost TargetMarket Outperform$16.50 ➝ $17.00
7/30/2021BTIG ResearchReiterated RatingBuy$16.50
5/5/2021Raymond James FinancialBoost TargetOutperform$15.00 ➝ $16.50
4/30/2021BTIG ResearchReiterated RatingBuy$14.50
4/26/2021JPMorgan Chase & Co.Boost TargetNeutral$12.50 ➝ $13.50
3/17/2021Credit Suisse GroupBoost TargetOutperform$13.00 ➝ $16.00
2/25/2021Raymond James FinancialBoost TargetOutperform$12.00 ➝ $15.00
2/2/2021BTIG ResearchInitiated CoverageBuy$13.50
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.84 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 8 very positive mentions
  • 10 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 13 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/8/2025
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 2 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/7/2025
  • 8 very positive mentions
  • 0 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
9/6/2025
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 3 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Ares Commercial Real Estate logo
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt and preferred equity products, mezzanine loans, and other CRE investments, including commercial mortgage-backed securities. It has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Corporation was incorporated in 2011 and is based in New York, New York.
Read More

Today's Range

Now: $5.15
Low: $5.13
High: $5.30

50 Day Range

MA: $4.75
Low: $4.40
High: $5.30

52 Week Range

Now: $5.15
Low: $3.35
High: $7.27

Volume

398,615 shs

Average Volume

479,375 shs

Market Capitalization

$283.13 million

P/E Ratio

N/A

Dividend Yield

11.32%

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Commercial Real Estate?

The following sell-side analysts have issued stock ratings on Ares Commercial Real Estate in the last year: JMP Securities, JPMorgan Chase & Co., Keefe, Bruyette & Woods, UBS Group AG, Wall Street Zen, Weiss Ratings, and Zacks Research.
View the latest analyst ratings for ACRE.

What is the current price target for Ares Commercial Real Estate?

0 Wall Street analysts have set twelve-month price targets for Ares Commercial Real Estate in the last year. Their average twelve-month price target is $5.08, suggesting a possible downside of 1.2%. JPMorgan Chase & Co. has the highest price target set, predicting ACRE will reach $5.50 in the next twelve months. Keefe, Bruyette & Woods has the lowest price target set, forecasting a price of $4.75 for Ares Commercial Real Estate in the next year.
View the latest price targets for ACRE.

What is the current consensus analyst rating for Ares Commercial Real Estate?

Ares Commercial Real Estate currently has 1 sell rating and 5 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for ACRE.

What other companies compete with Ares Commercial Real Estate?

Other companies that are similar to Ares Commercial Real Estate include Apollo Commercial Real Estate Finance, BrightSpire Capital, Blackstone Mortgage Trust, Chimera Investment and KKR Real Estate Finance Trust. Learn More about companies similar to Ares Commercial Real Estate.

How do I contact Ares Commercial Real Estate's investor relations team?

Ares Commercial Real Estate's physical mailing address is 245 PARK AVENUE 42ND FLOOR, NEW YORK NY, 10167. The real estate investment trust's listed phone number is (212) 710-2100 and its investor relations email address is [email protected]. The official website for Ares Commercial Real Estate is www.arescre.com. Learn More about contacing Ares Commercial Real Estate investor relations.